This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

The introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the childhood
immunisation programme in Norway in 2006 substantially decreased the incidence of vaccine-…

In 2006, the heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the
Norwegian Childhood Vaccination Programme in a 2+1 dose schedule; immunisations are …

Background Approximately 90% of new tuberculosis (TB) cases notified in Norway are
asylum seekers and other immigrants from high-incidence countries. Asylum seekers are …

In March 2014 a 20-year-old man was diagnosed with cutaneous diphtheria at St. Olavs
University Hospital in Trondheim, Norway on his return from Africa. The man had been in …

Bakgrunn Tuberkulose skyldes bakteriearter i Mycobacterium tuberculosis-komplekset, som
i hovedsak spres ved luftbåren smitte fra en pasient med smittsom lungetuberkulose til …

We have eliminated measles and rubella in Norway, but are still exposed to infection from
abroad. The high vaccination coverage for children must be maintained, and non-immune …

Surveillance of antimicrobial resistance is usually based on prevalences of reduced
susceptibility and resistance to certain combinations of antimicrobials and bacterial species in …

Antall eldre øker stadig i den vestlige verden. Et stort antall mennesker tilbringer sin siste tid
i institusjon, mange av dem i sykehjem. Mange sykehjemsklienter har infeksjoner …

Dette er et relativt stort antall i dagens Norge. Meslinger er blitt en forholdsvis sjelden sykdom
etter at MMR-vaksine ble innført i barnevaksinasjonsprogrammet i 1969. I perioden 2001–…